- Report
- November 2025
- 103 Pages
Global
From €3500EUR$4,028USD£3,030GBP
- Report
- July 2026
- 145 Pages
Global
From €3500EUR$4,028USD£3,030GBP
- Report
- March 2026
- 104 Pages
Global
From €3500EUR$4,028USD£3,030GBP
- Report
- March 2026
- 160 Pages
Global
From €3500EUR$4,028USD£3,030GBP
- Training
- September 2027
- 2 Days
Global
€1608EUR$1,788USD£1,299GBP
€1855EUR$2,063USD£1,499GBP
- Training
- February 2027
- 2 Days
Global
€1608EUR$1,788USD£1,299GBP
€1855EUR$2,063USD£1,499GBP
- Report
- June 2026
- 171 Pages
Global
From €4328EUR$4,650USD£3,619GBP
- Report
- October 2025
- 91 Pages
Global
From €4188EUR$4,500USD£3,503GBP
- Report
- October 2025
- 89 Pages
Global
From €4188EUR$4,500USD£3,503GBP
- Report
- September 2026
Asia Pacific
From €4466EUR$4,799USD£3,735GBP
- Report
- June 2026
- 120 Pages
Middle East
From €5538EUR$5,950USD£4,631GBP
- Report
- December 2025
- 81 Pages
Europe
From €3025EUR$3,250USD£2,530GBP
- Report
- December 2025
- 71 Pages
Asia Pacific
From €3025EUR$3,250USD£2,530GBP
- Report
- June 2026
- 273 Pages
North America
From €1396EUR$1,500USD£1,168GBP
- Report
- June 2026
- 372 Pages
Europe
From €1396EUR$1,500USD£1,168GBP
- Report
- June 2026
- 370 Pages
Asia Pacific
From €1396EUR$1,500USD£1,168GBP
- Report
- June 2026
- 371 Pages
Africa, Middle East
From €1396EUR$1,500USD£1,168GBP
- Report
- March 2026
Asia Pacific
From €3211EUR$3,450USD£2,685GBP
- Report
- March 2026
North America
From €3211EUR$3,450USD£2,685GBP
- Report
- September 2025
- 393 Pages
Global
From €5383EUR$5,987USD£4,350GBP

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more